Five University of Colorado Cancer Center Advancements That Changed the Game for Patients

The University of Colorado Cancer Center this year celebrates its 40th anniversary, highlighting significant advances in research and innovations that include new therapies, treatments and insights into cancer prevention. One of the leaders in cell-based immune therapies is CU Cancer Center member Terry Fry, M.D., executive director of the Gates Institute, a translational research institute on the CU Anschutz Medical Campus that produces CAR T and other cellular therapies for research. Gates recently launched a clinical trial of a CAR for pediatric patients with relapsed or refractory pre B-cell acute lymphoblastic leukemia (B-ALL).